Allergen immunotherapy.
Allergen immunotherapy has been used since the early 1900's for the treatment of allergic syndromes. The efficacy of immunotherapy for the treatment of anaphylaxis caused by the sting of the Hymenoptera class of insects, allergic rhinoconjunctivitis, and the allergic component of bronchial asthma has been clearly demonstrated in numerous well-designed, placebo-controlled trials. Many recent advances in our understanding of the cellular and molecular basis of the allergic response have permitted the development of innovative experimental approaches that very likely will improve the control of the allergic response in the future.
Wild
L G
LG
Lopez
M
M
D000328:Adult; D000485:Allergens / Q000276:immunology / Q000627:therapeutic use*; D000818:Animals; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D005260:Female; D006801:Humans; D006927:Hymenoptera; D006969:Hypersensitivity, Immediate / Q000276:immunology / Q000628:therapy*; D007167:Immunotherapy / Q000379:methods* / Q000639:trends*; D007223:Infant; D007299:Insect Bites and Stings / Q000628:therapy; D018579:Patient Selection; D011247:Pregnancy
D000485:Allergens